KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Non-Current Debt (2017 - 2025)

Astrana Health (ASTH) has disclosed Non-Current Debt for 12 consecutive years, with $990.9 million as the latest value for Q4 2025.

  • Quarterly Non-Current Debt rose 132.99% to $990.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $990.9 million through Dec 2025, up 132.99% year-over-year, with the annual reading at $990.9 million for FY2025, 132.99% up from the prior year.
  • Non-Current Debt hit $990.9 million in Q4 2025 for Astrana Health, down from $1.0 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $1.0 billion in Q3 2025 to a low of $182.7 million in Q2 2021.
  • Historically, Non-Current Debt has averaged $343.8 million across 5 years, with a median of $216.6 million in 2021.
  • Biggest five-year swings in Non-Current Debt: fell 20.72% in 2021 and later skyrocketed 136.82% in 2025.
  • Year by year, Non-Current Debt stood at $182.9 million in 2021, then rose by 11.19% to $203.4 million in 2022, then rose by 27.31% to $258.9 million in 2023, then soared by 64.25% to $425.3 million in 2024, then soared by 132.99% to $990.9 million in 2025.
  • Business Quant data shows Non-Current Debt for ASTH at $990.9 million in Q4 2025, $1.0 billion in Q3 2025, and $401.1 million in Q2 2025.